BioPharm Webinar | Optimizing Freeze Thaw Processes for Cell and Gene Therapy Commercialization
Numerous cell and gene therapy workflows rely on the ability of the process to be halted and re-established via freezing and thawing of intermediate and final product formulations. Early process and tool decisions can help overcome future complexity and uncertainty. See how to address freeze/thaw manufacturing capacity and infrastructure challenges by working in partnership with a well-resourced freeze/thaw ecosystem center.
スピーカー
- Ross Acucena | Applications Director, Life Sciences
2022年04月12日 - 2022年04月12日
VIEW WEBINAR, REGISTER NOW
ON DEMAND
BioPharm Webinar | Optimizing Freeze Thaw Processes for Cell and Gene Therapy Commercialization
April 12, 2022 2:00 PM
April 12, 2022 3:00 PM
ON DEMAND
Numerous cell and gene therapy workflows rely on the ability of the process to be halted and re-established via freezing and thawing of intermediate and final product formulations. Early process and tool decisions can help overcome future complexity and uncertainty. See how to address freeze/thaw manufacturing capacity and infrastructure challenges by working in partnership with a well-resourced freeze/thaw ecosystem center.
/content/entegris-live/ja/home/about-us/events/optimizing-freeze-thaw-processes-for-cell-and-gene-therapy-commercialization-biopharm-april-2022
Recorded Webinar
In this webcast, Ross discusses how freeze/thaw ecosystem access provides:
- Facilities and infrastructure to design and deploy optimized workflows
- Single-use systems that protect the integrity, efficacy, and purity of your product
- Capabilities to support your achieving critical clinical development and commercialization
